Showing 119 of 119on this page. Filters & sort apply to loaded results; URL updates for sharing.119 of 119 on this page
DLL3 – A Breakthrough Target for Small Cell Lung Cancer Therapy-DIMA ...
DLL3 Emerges as an Actionable Target in Small Cell Lung Cancer ...
Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate ...
DLL3 Targeting in Small Cell Lung Cancer | BioRender Science Templates
Delta‐like ligand 3: A promising target against small cell lung cancer ...
DLL3: A New Molecular Target in Cancer - Cusabio
(PDF) DLL3: An emerging target in small cell lung cancer
Near infrared photoimmunotherapy targeting DLL3 for small cell lung ...
DLL3 regulates Notch signaling in small cell lung cancer: iScience
Investigational DLL3 & T-Cell Engager Technology for SCLC | DLL3 ...
Allogeneic CAR T Cells Targeting DLL3 Are Efficacious and Safe in ...
Henlius’ DLL3 × CD3 × CD28 Tri-specific TCE: An Integration of ...
DLL3: Emerging Target in Tumor Therapy Treatment Strategies | KACTUS
Targeting DLL3 in Small Cell Lung Cancer and Other Neuroendocrine ...
Non-invasive Interrogation of DLL3 Expression in Metastatic Small Cell ...
P1.12-07 Near Infrared Photoimmunotherapy Targeting DLL3 Against Small ...
DLL3 Targeted Therapies Market, Approved Drugs Dosage, Pricing ...
DLL3 Antibody (703623)
Noninvasive Interrogation of DLL3 Expression in Metastatic Small Cell ...
DLL3 regulates the migration and invasion of small cell lung cancer by ...
AACR 2025: Bispecific antibody drug conjugates (bsADCs) targeting DLL3 ...
Impact of DLL3 Expression as Prognostic Factor in Extensive Stage of ...
Frontiers | Advances in DLL3-targeted therapies for small cell lung ...
Advances in adoptive cell therapies in small cell lung cancer
小细胞肺癌的治疗靶点DLL3
Targeting DLL3: Innovative Strategies for Tumor Treatment
Advancement Opportunities and Endeavor of Innovative Targeted Therapies ...
Targeting the Notch signaling pathway and the Notch ligand, DLL3, in ...
DLL3: The Next Breakthrough in Small Cell Lung Cancer
【最强组合】肺癌治疗热门靶点——DLL3 & Notch - 自主发布 - 生物在线 Lab-on-Web
2023 WCLC | 小细胞肺癌的探索：DLL3靶向药物，B7-H3 ADC 小细胞肺癌（SCLC）约占肺癌的14%，且预后不良，广泛期患者 ...
DLL3/CD3 T-cell engager | InOncology – Boehringer Ingelheim
Combined DLL3-targeted bispecific antibody with PD-1 inhibition is ...
针对小细胞肺癌靶向DLL3的新疗法|肺癌|疗法|患者|治疗|-健康界
Emerging therapies targeting the delta-like ligand 3 (DLL3) in small ...
Taking a Bite Out of Small Cell Lung Cancer By Leveraging Precision ...
Transitioning to a Personalized Approach in Molecularly Subtyped Small ...
A Bispecific DLL3/CD3 IgG-Like T-Cell Engaging Antibody Induces ...
FDA Clears IND for Novel DLL3-Targeted ADC in Solid Tumors | Targeted ...
"Validating DLL3-targeting CAR T in small cell lung cancer" by Bingnan ...
(PDF) Combined DLL3-targeted bispecific antibody with PD-1 inhibition ...
勃林格殷格翰小细胞肺癌新药DLL3/CD3双抗II期临床试验在中国获批 - 中金投X
Targets and biomarkers for targeted therapy. DLL3, delta-like protein ...
A DLL3-targeted theranostic for small cell lung cancer: Imaging a low ...
DLL3：多赛道进击小细胞肺癌|肺癌|细胞|信号|配体|-健康界
(PDF) Emerging therapies targeting the delta-like ligand 3 (DLL3) in ...
Programs & Pipeline | Mariana Oncology
Anti-DLL3 ADC - Creative Biolabs
针对小细胞肺癌靶向DLL3的新疗法@MedSci
FDA Grants Fast Track Designation to DLL3-Targeted ADC ZL-1310 in ES ...
Engineering CD3/CD137 Dual Specificity into a DLL3-Targeted T-Cell ...
DLL3-Targeting BiTE® Therapy for 2L+ ES-SCLC | IMDELLTRA® (tarlatamab ...
DLL3：多赛道进击小细胞肺癌 - 知乎
Our goal of transforming the treatment of neuroendocrine carcinomas ...
Delta-like ligand 3 (DLL3) landscape in pulmonary and extra-pulmonary ...
MA17.13 DLL3-targeted CAR-T Therapy of Small Cell Lung Cancer Utilizing ...
Small-cell lung cancer: insights and new treatment options centering ...
SITC 2025: Bispecific Antibody-Drug Conjugates Targeting DLL3×B7-H3 and ...
二线大胜：安进启动DLL-3/CD3双抗第2项小细胞肺癌一线三期临床
(PDF) DLL3-guided therapies in small-cell lung cancer: from antibody ...
